Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells.
about
Metabolism of vertebrate amino sugars with N-glycolyl groups: elucidating the intracellular fate of the non-human sialic acid N-glycolylneuraminic acidColloquium paper: uniquely human evolution of sialic acid genetics and biologyDefining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophilsDysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic AgentsStructural and functional characteristics of bovine milk protein glycosylationRacotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical dataN-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible.Antiphospholipid antibodies: paradigm in transition.Prevalence of anti-Neu5Gc antibodies in patients with hypothyroidism.Alteration of the N-glycome of bovine milk glycoproteins during early lactation.Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid.LC-MS analysis of polyclonal human anti-Neu5Gc xeno-autoantibodies immunoglobulin G Subclass and partial sequence using multistep intravenous immunoglobulin affinity purification and multienzymatic digestion.A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophySialic acid speciation using capillary electrophoresis: optimization of analyte derivatization and separation.Racotumomab-alum vaccine for the treatment of non-small-cell lung cancer.A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki diseaseExploration of sialic acid diversity and biology using sialoglycan microarrays.Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.Heart disease is common in humans and chimpanzees, but is caused by different pathological processes.Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid.Metabolism of vertebrate amino sugars with N-glycolyl groups: incorporation of N-glycolylhexosamines into mammalian glycans by feeding N-glycolylgalactosamineAnti-ganglioside anti-idiotypic vaccination: more than molecular mimicry.The glycans of stem cells.Sialic acids in human health and disease.Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for diseaseEvidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression.Early determinants of development: a lipid perspective.Multiple changes in sialic acid biology during human evolution.Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis.Evidence for a novel human-specific xeno-auto-antibody response against vascular endothelium.Involvement of a non-human sialic Acid in human cancer.Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer.How innovative technology is moving biologics into the 21st century.Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation.Glycans as targets for therapeutic antitumor antibodies.The nutritional role of free sialic acid, a human milk monosaccharide, and its application as a functional food ingredient.Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance.Accelerated tumor growth mediated by sublytic levels of antibody-induced complement activation is associated with activation of the PI3K/AKT survival pathwayHuman antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties.Housekeeping promoter 5'pcmah-2 of pig CMP-N-acetylneuraminic acid hydroxylase gene for NeuGc expression.
P2860
Q24338142-CCE6CFD5-4024-479C-B574-EFE47DF168BAQ24634579-05C498C8-0F9B-49D7-8527-E233D0B67232Q24678441-2CEFDD68-C652-4F2D-B734-19B69E1592F2Q26771367-67CFC1EC-72DF-446B-9FB6-513785C78B4EQ26824272-3C98BBE0-BBF6-48C1-934A-F4F5C8435E3FQ30575331-6E8925D2-4656-45DE-B204-85BA0C3CCE06Q33258763-EFAEBC50-F3EF-45BD-9343-6DE6A4849B71Q33382848-DECB3E46-850F-49FC-B8A5-AA9FE249CC7CQ33805059-9009B746-9B6D-47CF-903A-8B0FEDA3C99BQ33990766-794FA13F-8637-448E-AC74-AC0C40AA632EQ34044438-5A76A97C-1EA6-460B-98A4-B30025AB5117Q34080004-208A528F-40F7-48F4-A8D7-745EEDC5C456Q34175938-178A29F8-43FF-4BC9-A5A4-8B4552E7167CQ34383299-E05D8302-329C-4716-8D02-987B519EB8AEQ34449304-2FCC8B53-C41A-43F9-B94E-7A76372D2EC8Q34631810-45700508-AE15-4E0F-8DB1-2B2BA717512BQ34772126-AD1A025A-7CD0-4334-9A6A-D3DE3EF2870AQ34900010-0A7FE9A6-3335-4291-BB21-71A072713805Q35960796-76B613C0-D0CD-4625-A195-B97218ABDC3FQ36217161-1E543F45-5C3D-4628-860A-5992521CA290Q36217214-297A5C84-91CA-43CC-8B96-3B33512D417BQ36410563-36615E66-DBC0-4262-98F9-CB666D779160Q36903397-0CB52A47-3EED-4A89-BE4B-6442BDCD2123Q36908164-90F840EA-BF04-4934-9CD8-8CC6D00622B8Q36981219-7C97F46D-8F98-4B7D-990C-D13779469155Q36999969-5231ACBC-58CC-4695-AEE0-0C1B9699C44FQ37179156-97A5AC36-6280-4F97-AEE8-9D4D75CF6229Q37262841-F82FCC41-DF35-484E-8A8A-621F4A63CAE4Q37393097-8AD06070-E3B3-4E5E-84D5-0AF25EE6A430Q37472019-CF77F2E5-A29B-4E78-9A57-B4A4554F628AQ37592596-B7673DBD-CF1B-4AAF-8978-BB79AFAE21D5Q37594945-3863C7C1-F16A-4564-A652-3F910158470DQ37693675-36BEF9BD-66FA-473E-9E4F-E5AC66D786CDQ38012151-C1379A1B-447A-4A93-822D-137A63BECB14Q38034815-4208ABE1-66A2-4D23-982A-3AD5AE9AA2BAQ38538651-54EEDC34-DCE5-4AA9-B9A4-6FE7EC519EA6Q38848896-69B82DD6-A03F-41EB-AB26-1DC9CCE9547EQ39129112-2F7BDB1A-0D8F-4A21-AAAF-5FF5F91A7FA4Q39210534-84747585-CF22-4668-B80A-C2F880CEF233Q40671232-274D690E-53FB-4529-A0E2-050892F4CD4B
P2860
Effects of natural human antibodies against a nonhuman sialic acid that metabolically incorporates into activated and malignant immune cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Effects of natural human antib ...... ed and malignant immune cells.
@en
type
label
Effects of natural human antib ...... ed and malignant immune cells.
@en
prefLabel
Effects of natural human antib ...... ed and malignant immune cells.
@en
P2093
P1476
Effects of natural human antib ...... ed and malignant immune cells.
@en
P2093
Ajit Varki
Dzung H Nguyen
Pam Tangvoranuntakul
P304
P356
10.4049/JIMMUNOL.175.1.228
P407
P577
2005-07-01T00:00:00Z